ASBPNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ASBPW
Aspire-Lakewood Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$8.41−0.37 (-4.21%)
Close on Oct 19, 2026
- Market cap
- $8.73M
- P/E (TTM)
- –
- Dividend yield
- –
Aspire-Lakewood Holdings, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | FY2025 | % of revenue |
|---|---|---|
| United States | $6.15K | 99.2% |
| Canada | $30 | 0.5% |
| United Kingdom | $19 | 0.3% |
From the segment and revenue-disaggregation notes of Aspire-Lakewood's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.